Span Divergent Share Price

  • 19.06-0.97 (-4.84%)
  • Volume: 200
BSE
  • Closed
  • Last Updated On: 29 Aug, 2024, 03:38 PM IST
Loading...

Span Divergent Share Pr...

  • 19.06-0.97 (-4.84%)
  • Volume: 200
Advertisment

Span Divergent share price insights

View All
  • Company has spent 5.83% of its operating revenues towards interest expenses and 18.61% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

  • Stock gave a 3 year return of 36.72% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

  • Stock generated 36.72% return as compared to BSE Healthcare which gave investors 65.22% return over 3 year time period. (as of last trading session)

  • Span Divergent Ltd. share price moved down by -4.84% from its previous close of Rs 20.03. Span Divergent Ltd. stock last traded price is 19.06

    Share PriceValue
    Today/Current/Last-19.06
    Previous Day-20.03

InsightsSpan Divergent

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    14.51
    EPS - TTM
    (₹)
    1.31
    MCap
    (₹ Cr.)
    10.41
    Sectoral MCap Rank
    49
    PB Ratio
    (x)
    -1.45
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month-0.41
    3 Months-0.74
    6 Months-0.41
    1 Year-0.07
    3 Years0.02

    -0.41
    VWAP
    (₹)
    19.08
    52W H/L
    (₹)
    36.33 / 10.23

    Span Divergent Share Price Returns

    1 Day-4.84%
    1 Week-4.7%
    1 Month-36.15%
    3 Months-21.11%
    1 YearN.A.
    3 Years30.1%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Span Divergent belongs to analysts' top-rated companies list?

    View Stock Screeners

    Span Divergent Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Span Divergent Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Span Divergent Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent 5.83% of its operating revenues towards interest expenses and 18.61% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income3.893.913.373.463.60
      Total Income Growth (%)-0.7516.13-2.61-3.94-0.22
      Total Expenses3.703.092.943.453.35
      Total Expenses Growth (%)19.974.94-14.892.99-52.34
      EBIT0.180.830.430.010.25
      EBIT Growth (%)-77.8192.390.00-97.19-
      Profit after Tax (PAT)-0.010.920.06-0.260.20
      PAT Growth (%)-100.601,322.84--234.75-
      EBIT Margin (%)4.7421.1912.790.206.91
      Net Profit Margin (%)-0.1423.551.92-7.625.43
      Basic EPS (₹)-0.161.620.12-0.550.24
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income0.741.430.670.660.70
      Total Income Growth (%)-48.70115.480.12-5.2610.35
      Total Expenses0.400.540.460.490.47
      Total Expenses Growth (%)-25.3017.75-6.654.09-86.74
      EBIT0.330.900.210.180.23
      EBIT Growth (%)-62.70328.3818.92-24.17-
      Profit after Tax (PAT)0.230.870.190.160.28
      PAT Growth (%)-73.60350.7218.29-40.84-
      EBIT Margin (%)45.4762.5531.4626.4933.10
      Net Profit Margin (%)31.3861.0029.1624.6839.53
      Basic EPS (₹)0.421.600.360.300.51
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue14.3513.1814.739.3311.87
      Total Revenue Growth (%)8.86-10.5257.81-21.38-53.04
      Total Expenses13.6414.5915.9314.3320.60
      Total Expenses Growth (%)-6.57-8.3511.12-30.43-44.22
      Profit after Tax (PAT)0.98-5.05-9.80-5.59-7.77
      PAT Growth (%)-----
      Operating Profit Margin (%)11.61-3.30-0.87-46.18-71.76
      Net Profit Margin (%)7.91-40.35-74.87-75.46-82.83
      Basic EPS (₹)1.43-9.93-18.59-11.28-15.77
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue3.462.703.123.213.20
      Total Revenue Growth (%)28.53-13.56-2.750.347.88
      Total Expenses2.041.882.022.073.15
      Total Expenses Growth (%)7.99-6.62-2.67-34.22-26.10
      Profit after Tax (PAT)1.51-3.34-7.760.00-0.35
      PAT Growth (%)-----
      Operating Profit Margin (%)74.6441.3856.0080.3116.05
      Net Profit Margin (%)78.86-170.36-394.96-0.12-20.51
      Basic EPS (₹)2.76-6.11-14.200.00-0.64

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets24.1925.5927.8334.4439.56
      Total Assets Growth (%)-5.49-8.03-19.20-12.96-19.70
      Total Liabilities31.7533.9530.7627.2226.21
      Total Liabilities Growth (%)-6.4710.3813.003.86-4.12
      Total Equity-7.57-8.36-2.937.2213.35
      Total Equity Growth (%)---140.62-45.96-39.12
      Current Ratio (x)0.460.420.521.151.17
      Total Debt to Equity (x)-4.83-3.505.081.481.05
      Contingent Liabilities0.004.0315.3815.3815.38
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets38.4637.6440.8749.8549.41
      Total Assets Growth (%)2.18-7.90-18.010.89-0.38
      Total Liabilities4.345.024.906.125.68
      Total Liabilities Growth (%)-13.552.45-19.937.753.09
      Total Equity34.1232.6235.9743.7343.72
      Total Equity Growth (%)4.60-9.31-17.750.02-0.84
      Current Ratio (x)3.242.492.934.604.20
      Total Debt to Equity (x)0.060.080.070.070.07
      Contingent Liabilities0.004.0314.5814.5814.58

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities2.501.987.03-0.21-0.12
      Net Cash used in Investing Activities0.120.53-2.051.995.89
      Net Cash flow from Financing Activities-2.09-2.30-5.50-1.41-7.32
      Net Cash Flow0.530.20-0.520.37-1.55
      Closing Cash & Cash Equivalent0.930.400.190.710.34
      Closing Cash & Cash Equivalent Growth (%)131.85105.56-72.76106.96-81.78
      Total Debt/ CFO (x)3.645.031.60-83.71-157.79
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities0.530.58-0.310.371.10
      Net Cash used in Investing Activities0.16-0.360.43-0.570.47
      Net Cash flow from Financing Activities-0.56-0.02-0.200.30-1.97
      Net Cash Flow0.130.20-0.080.10-0.41
      Closing Cash & Cash Equivalent0.380.250.050.130.03
      Closing Cash & Cash Equivalent Growth (%)51.18440.91-63.69302.70-92.82
      Total Debt/ CFO (x)3.914.36-8.358.452.61

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)-51.690.00-441.28-46.47-44.18
      Return on Capital Employed (%)-50.7718.32-2.42-16.77-27.81
      Return on Assets (%)4.03-19.75-35.21-16.22-19.63
      Interest Coverage Ratio (x)4.281.751.90-0.20-1.64
      Asset Turnover Ratio (x)0.500.470.420.0323.70
      Price to Earnings (x)9.58-1.44-0.69-1.24-0.93
      Price to Book (x)-4.95-2.563.030.570.41
      EV/EBITDA (x)3.856.446.08-60.96-6.40
      EBITDA Margin (%)24.9514.0015.68-4.21-34.97
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)4.42-10.23-21.560.00-0.80
      Return on Capital Employed (%)3.902.282.812.460.59
      Return on Assets (%)3.92-8.86-18.980.00-0.70
      Interest Coverage Ratio (x)0.000.000.0050.251.19
      Asset Turnover Ratio (x)0.050.050.040.033.45
      Price to Earnings (x)6.19-2.18-0.87-5,000.00-20.66
      Price to Book (x)0.270.220.190.160.17
      EV/EBITDA (x)6.247.625.605.458.45
      EBITDA Margin (%)92.4663.0581.92125.0769.65

    Financial InsightsSpan Divergent

    • Income (P&L)
      • Employee & Interest Expense

        Company has spent 5.83% of its operating revenues towards interest expenses and 18.61% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Span Divergent Peer Comparison

    • Span Divergent Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 36.72% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)
      • Stock Returns vs BSE Healthcare

        Stock generated 36.72% return as compared to BSE Healthcare which gave investors 65.22% return over 3 year time period. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 36.72% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)
      • Stock Returns vs BSE Healthcare

        Stock generated 36.72% return as compared to BSE Healthcare which gave investors 65.22% return over 3 year time period. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Span Divergent 14.51-1.38-51.69-50.774.0315.2511.616.321.430.46-4.833.64
      Nureca Ltd523.491.56-0.92-1.04-0.87-21.85-2.23-1.95-1.7920.770.00-0.18
      Denis Chem Lab21.492.8213.8819.0810.2015.399.346.648.042.550.010.06
      Constronics Infra197.94128.5574.2412.0710.89-6.21101.1192.750.1053.655.73-32.58
      Shree Pacetronix23.495.1625.7636.6315.4442.3122.6215.239.331.850.34-36.36
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Transgene Biotek
      • GKB Ophthalmics
      • Bandaram Pharma Pack
      • Centenial Surg
      • Kretto Syscon

      Choose from Stocks

      Peers InsightsSpan Divergent

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 36.72% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

      • Stock Returns vs BSE Healthcare

        Stock generated 36.72% return as compared to BSE Healthcare which gave investors 65.22% return over 3 year time period. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Span Divergent Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Span Divergent Shareholding as on 30 Jun 2024
        Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
        Promoters64.0164.0164.0164.01
        Pledge0.000.000.000.00
        FII0.000.000.000.00
        DII0.000.000.000.00
        Mutual Funds0.000.000.000.00
        Others35.9835.9835.9835.98
      • Showing Shareholding as on 30 Jun 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters34,95,90064.01 %0.00
        Pledge00.00 %0.00
        Others19,65,84735.98 %0.00

      MF Ownership

      MF Ownership details are not available.

      Corporate Actions

      • Span Divergent Board Meeting/AGM

      • Span Divergent Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        Aug 13, 2024Aug 06, 2024Board MeetingQuarterly Results
        May 16, 2024May 08, 2024Board MeetingAudited Results & Final Dividend
        Feb 12, 2024Feb 05, 2024Board MeetingQuarterly Results
        Nov 09, 2023Nov 01, 2023Board MeetingQuarterly Results
        Sep 28, 2023May 22, 2023AGMA.G.M.
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final5%0.5Jul 16, 2013May 15, 2013
        Final 10%1.0Jul 26, 2011May 20, 2011
        Final 25%2.5Jun 18, 2010Jun 07, 2010
        Final 20%2.0Aug 08, 2008Jun 30, 2008
        Final 18%1.8Aug 10, 2007Jun 25, 2007
      • All TypesEx-DateRecord DateAnnounced onDetails
        BonusJul 27, 2010Jul 28, 2010Jun 05, 2010Bonus Ratio: 1 share(s) for every 1 shares held

      About Span Divergent

      Span Divergent Ltd., incorporated in the year 1980, is a Small Cap company (having a market cap of Rs 10.41 Crore) operating in Hospitals & Allied Services sector. Span Divergent Ltd. key Products/Revenue Segments include Other Operating Revenue for the year ending 31-Mar-2022. Show More

      • Executives

      • Auditors

      • NG

        N Gopalaswami

        Chairman
        VP

        Viral P Desai

        Managing Director
        PD

        Paras Desai

        WholeTime Director & CFO
        KP

        Kamlesh Patel

        Director
        Show More
      • Y B Desai & Associates.
        Haribhakti & Co. LLP

      FAQs about Span Divergent share

      • 1. What's the Span Divergent share price today?
        Span Divergent share price was Rs 19.06 as on 29 Aug, 2024, 03:38 PM IST. Span Divergent share price was down by 4.84% based on previous share price of Rs. 20.01.
      • 2. What is the PE & PB ratio of Span Divergent ?
        The PE ratio of Span Divergent stands at 15.25, while the PB ratio is -1.45.
      • 3. What are the Span Divergent quarterly results?
        On Consoldiated basis, Span Divergent reported a total income and loss of Rs 3.89 Cr and Rs -0.01 respectively for quarter ending 2024-06-30. Total Income and profit for the year ending 2024-03-31 was Rs 14.35 Cr and Rs 0.98 Cr.
      • 4. What are the returns for Span Divergent share?
        Return Performance of Span Divergent Shares:
        • 1 Week: Span Divergent share price moved down by 4.70%
        • 3 Month: Span Divergent share price moved down by 21.11%
      • 5. What is the CAGR of Span Divergent ?
        The CAGR of Span Divergent is 13.61.
      • 6. Who's the chairman of Span Divergent ?
        N Gopalaswami is the Chairman of Span Divergent
      • 7. How can I quickly analyze Span Divergent stock?
        Span Divergent share can be quickly analyzed on following metrics:
        • Stock's PE is 14.51
        • Price to Book Ratio of -1.45
      • 8. What dividend is Span Divergent giving?
        An equity Final dividend of Rs 0.5 per share was declared by Span Divergent Ltd. on 15 May 2013. So, company has declared a dividend of 5% on face value of Rs 10 per share. The ex dividend date was 16 Jul 2013.
      • 9. Who are the peers for Span Divergent in Hospitals & Allied Services sector?
        Within Hospitals & Allied Services sector Span Divergent , Transpact Enterprises Ltd., Kretto Syscon Ltd., Bandaram Pharma Packtech Ltd., Centenial Surgical Suture Ltd., Shree Pacetronix Ltd., GKB Ophthalmics Ltd., Transgene Biotek Ltd., Constronics Infra Ltd., Denis Chem Lab Ltd. and Nureca Ltd. are usually compared together by investors for analysis.
      • 10. Who's the owner of Span Divergent ?
          • Promoter holding has not changed in last 9 months and holds 64.01 stake as on 30 Jun 2024
          • Other investor holding has not changed in last 9 months and holds 35.98 stake as on 30 Jun 2024
      • 11. What is 52 week high/low of Span Divergent share price?
        In last 52 weeks Span Divergent share had a high price of Rs 36.33 and low price of Rs 10.23
      • 12. What's the market capitalization of Span Divergent ?
        Market Capitalization of Span Divergent stock is Rs 10.41 Cr.

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times